Ads

 

Ads

 

Ads

 

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biopharmaceutical Companies 2024
Metatag Abstract
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.
  1. Mirum Pharmaceuticals

    World Rank (Jan-05-2024)
    7,121
    Market Cap (Jan-05-2024)
    1.384 Billion USD
    World Rank (Jul-30-2023)
    8,800
    Market Cap (Jul-30-2023)
    0.988 Billion USD
    World Rank (Dec-25-2022)
    10,559
    Market Cap (Dec-25-2022)
    0.673 Billion USD
    World Rank (Jan-07-2022)
    13,731
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Mirum Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on clinical studies for the treatment of cholestatic diseases including primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP) and primary biliary cholangitis (PBC). It is having 24 employees as on 2019. The headquarters is in USA.
  2. Xencor

    World Rank (Jan-05-2024)
    7,236
    Market Cap (Jan-05-2024)
    1.346 Billion USD
    World Rank (Jul-30-2023)
    7,028
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,390
    Market Cap (Dec-25-2022)
    1.564 Billion USD
    World Rank (Jan-07-2022)
    5,875
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    164 Million USD
    Annual Operating Income in USD
    -82 Million USD
    Annual Net Income in USD
    -55 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
    Facts About Company
    As on 2021, Xencor had 254 full-time employees.
  3. Agios Pharmaceuticals

    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -389 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
  4. Protagonist Therapeutics

    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    27 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -127 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

  5. Sage Therapeutics

    World Rank (Jan-05-2024)
    7,382
    Market Cap (Jan-05-2024)
    1.301 Billion USD
    World Rank (Jul-30-2023)
    5,572
    Market Cap (Jul-30-2023)
    2.089 Billion USD
    World Rank (Dec-25-2022)
    4,977
    Market Cap (Dec-25-2022)
    2.288 Billion USD
    World Rank (Jan-07-2022)
    5,501
    Market Cap (Jan-07-2022)
    2.48 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Operating Income in USD
    -546 Million USD
    Annual Net Income in USD
    -532 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio Pharmaceutical company with headquarters is in Massachusetts, USA.
  6. Akero Therapeutics

    World Rank (Jan-05-2024)
    7,478
    Market Cap (Jan-05-2024)
    1.272 Billion USD
    World Rank (Jul-30-2023)
    5,174
    Market Cap (Jul-30-2023)
    2.349 Billion USD
    World Rank (Dec-25-2022)
    4,983
    Market Cap (Dec-25-2022)
    2.284 Billion USD
    World Rank (Jan-07-2022)
    11,418
    Market Cap (Jan-07-2022)
    0.70 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -115 Million USD
    Annual Net Income in USD
    -112 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Akero Therapeutics is a Biotechnology company focused on reverse the course of serious metabolic diseases and transform patients. The headquarters is in USA.
  7. Peptidream

    World Rank (Jan-05-2024)
    7,512
    Market Cap (Jan-05-2024)
    1.258 Billion USD
    World Rank (Jul-30-2023)
    6,400
    Market Cap (Jul-30-2023)
    1.676 Billion USD
    World Rank (Dec-25-2022)
    6,147
    Market Cap (Dec-25-2022)
    1.649 Billion USD
    World Rank (Jan-07-2022)
    5,361
    Market Cap (Jan-07-2022)
    2.59 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    PeptiDream is a Biopharmaceutical company. It is the platform which enables the production of highly diverse non standard peptide libraries with high efficiency for the identification of highly potent and selective hit candidates which then can be developed into peptide based, small molecule based or peptide drug conjugate based therapeutics. The headquarters is in Japan.
  8. Day One Biopharmaceuticals Inc.

    World Rank (Jan-05-2024)
    7,553
    Market Cap (Jan-05-2024)
    1.246 Billion USD
    World Rank (Jul-30-2023)
    8,115
    Market Cap (Jul-30-2023)
    1.136 Billion USD
    World Rank (Dec-25-2022)
    6,738
    Market Cap (Dec-25-2022)
    1.431 Billion USD
    World Rank (Jan-07-2022)
    9,477
    Market Cap (Jan-07-2022)
    0.99 Billion USD
    Annual Operating Income in USD
    -142 Million USD
    Annual Net Income in USD
    -142 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Day One Biopharmaceuticals Inc is a clinical stage biopharmaceutical company developing targeted therapies for patients of all ages with life threatening diseases. The headquarters is in USA.
  9. Cincor Pharma Inc.

    World Rank (Jan-05-2024)
    7,569
    World Rank (Jul-30-2023)
    7,569
    Market Cap (Jul-30-2023)
    1.270 Billion USD
    World Rank (Dec-25-2022)
    12,352
    Market Cap (Dec-25-2022)
    0.504 Billion USD
    World Rank (Jan-07-2022)
    10,873
    Headquarters Country
    Company Profile
    CinCor Pharma Inc is a clinical stage biopharmaceutical company focused on developing lead clinical candidate, baxdrostat (CIN-107), for the treatment of hypertension and other cardio-renal diseases. The headquarters is in United States.
  10. Ligand Pharmaceuticals

    World Rank (Jan-05-2024)
    7,621
    Market Cap (Jan-05-2024)
    1.227 Billion USD
    World Rank (Jul-30-2023)
    7,940
    Market Cap (Jul-30-2023)
    1.175 Billion USD
    World Rank (Dec-25-2022)
    5,769
    Market Cap (Dec-25-2022)
    1.822 Billion USD
    World Rank (Jan-07-2022)
    5,576
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Annual Revenue in USD
    196 Million USD
    Annual Operating Income in USD
    3 Million USD
    Annual Net Income in USD
    -33 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Ligand Pharmaceuticals is a Biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It is providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The headquarters is in USA.

Share

Ads